BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8405227)

  • 1. The effects of treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on human polymorphonuclear leukocyte function.
    Buescher ES; McIlheran SM; Banks SM; Vadhan-Raj S
    Exp Hematol; 1993 Oct; 21(11):1467-72. PubMed ID: 8405227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIXY321 (GM-CSF/IL-3 fusion protein): biology and early clinical development.
    Vadhan-Raj S
    Stem Cells; 1994 May; 12(3):253-61. PubMed ID: 8075592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin 3 fusion protein, on human tumor colony-forming units taken directly from patients.
    Izquierdo MA; Degen D; Raymond E; Caron D; Ortiz V; Banks P; Von Hoff DD
    Clin Cancer Res; 1996 Oct; 2(10):1713-6. PubMed ID: 9816121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic effects and clinical uses of granulocyte-macrophage colony-stimulating factor and PIXY321.
    Anderson JE; Appelbaum FR
    Curr Opin Hematol; 1994 May; 1(3):203-9. PubMed ID: 9371283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modulation of the oxidative burst of human neutrophils by pro- and anti-inflammatory cytokines].
    Gougerot-Podicalo MA; Elbim C; Chollet-Martin S
    Pathol Biol (Paris); 1996 Jan; 44(1):36-41. PubMed ID: 8734298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A GM-CSF/IL-3 fusion protein promotes neutrophil and platelet recovery in sublethally irradiated rhesus monkeys.
    Williams DE; Dunn JT; Park LS; Frieden EA; Seiler FR; Farese AM; Macvittie TJ
    Biotechnol Ther; 1993; 4(1-2):17-29. PubMed ID: 8374510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma.
    Vadhan-Raj S; Papadopoulos NE; Burgess MA; Linke KA; Patel SR; Hays C; Arcenas A; Plager C; Kudelka AP; Hittelman WN
    J Clin Oncol; 1994 Apr; 12(4):715-24. PubMed ID: 8151315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study.
    Vadhan-Raj S; Broxmeyer HE; Andreeff M; Bandres JC; Buescher ES; Benjamin RS; Papadopoulos NE; Burgess A; Patel S; Plager C; Hittelman WN; McAlister I; Garrison L; Williams DE
    Blood; 1995 Sep; 86(6):2098-105. PubMed ID: 7662957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of transcriptional activation of the immediate early gene Egr-1 in response to PIXY321.
    Mignacca RC; Lee HJ; Kwon EM; Sakamoto KM
    Blood; 1996 Aug; 88(3):848-54. PubMed ID: 8704240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin and chemokine mRNA expression in patient post-chemotherapy and in vitro cytokine-treated marrow stromal cell layers.
    Schwartz GN; Kammula U; Warren MK; Park MK; Yan XY; Marincola FM; Gress RE
    Stem Cells; 2000; 18(5):331-42. PubMed ID: 11007917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro production of megakaryocytes from PIXY321 versus GM-CSF-mobilized peripheral blood progenitor cells.
    Lefebvre P; Winter JN; Rademaker AW; Goolsby C; Cohen I
    Stem Cells; 1997; 15(2):112-8. PubMed ID: 9090787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factors G-CSF and GM-CSF differentially preserve chemotaxis of neutrophils aging in vitro.
    Wolach B; van der Laan LJ; Maianski NA; Tool AT; van Bruggen R; Roos D; Kuijpers TW
    Exp Hematol; 2007 Apr; 35(4):541-50. PubMed ID: 17379064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte macrophage-colony stimulating factor delays neutrophil apoptosis and primes its function through Ia-type phosphoinositide 3-kinase.
    Yasui K; Sekiguchi Y; Ichikawa M; Nagumo H; Yamazaki T; Komiyama A; Suzuki H
    J Leukoc Biol; 2002 Nov; 72(5):1020-6. PubMed ID: 12429725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer Group.
    Cairo MS; Krailo MD; Weinthal JA; Secola R; Bergeron S; van de Ven C; Blazar BR; Garrison L; Reaman GH
    Cancer; 1998 Oct; 83(7):1449-60. PubMed ID: 9762948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid cytokines as hematopoietic growth factors.
    Williams DE; Park LS; Broxmeyer HE; Lu L
    Int J Cell Cloning; 1991 Nov; 9(6):542-7. PubMed ID: 1770228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NADPH oxidase activity and chemotaxis by neutrophils in two patients with glycogen storage disease type Ib treated with recombinant human granulocyte-monocyte colony-stimulating factor.
    Piva E; De Toni S; Bovo C; Bordugo A; Burlina AB; Plebani M
    Haematologica; 1996; 81(2):148-51. PubMed ID: 8641644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cells.
    Roman-Unfer S; Bitran JD; Garrison L; Proeschel C; Hanauer S; Schroeder L; Johnson L; Klein L; Martinec J
    Exp Hematol; 1996 Jun; 24(7):823-8. PubMed ID: 8647233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inhibitor of ornithine decarboxylase antagonizes superoxide generation by primed human polymorphonuclear leukocytes.
    Walters JD; Cario AC; Danne MM; Marucha PT
    J Inflamm; 1998; 48(1):40-6. PubMed ID: 9368191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.